Related Experiment Video

Updated: Mar 28, 2026

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
05:56

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on: January 9, 2019

8.4K

[Clinic significance of liver function evaluation before hepatocellular carcinoma ablation]

Yu Wang, Jidong Jia1

  • 1Email: jiamd@263.net.

Zhonghua Yi Xue Za Zhi
|December 30, 2015
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

1.8K
Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
06:11

Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique

Published on: May 2, 2025

717

Related Experiment Videos

Last Updated: Mar 28, 2026

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases
05:56

Evaluation of the Feasibility, Safety, and Accuracy of an Intraoperative High-intensity Focused Ultrasound Device for Treating Liver Metastases

Published on: January 9, 2019

8.4K
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
09:51

Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience

Published on: December 4, 2023

1.8K
Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
06:11

Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique

Published on: May 2, 2025

717

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

256
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
256
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

334
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
334

Articles linked to this work by shared authors, journal, and citation graph.

Optimizing nonlinear absorption via modulating π-electron delocalization in multi-ring conjugated cores: from TPA at 515/650 nm to broad temporal response.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2026

A global consensus on the critical care management of acute-on-chronic liver failure patients: the APASL ACLF Beijing Position Paper.

Hepatology international·2026

Integrated Bio-inspired Synergistic Framework with Self-Sensing Control for Anthropomorphic Coordination of TCP-Driven Hands.

Bioinspiration & biomimetics·2026

Chronic Hepatitis B in the Asia-Pacific Region: Results of the 2023 Global Burden of Disease Study.

Journal of clinical and translational hepatology·2026

Outcomes of nucleos(t)ide analogue discontinuation following finite xalnesiran-based therapies in chronic hepatitis B.

JHEP reports : innovation in hepatology·2026

APASL clinical practice guidelines on the management of chronic hepatitis B infection: a 2026 update.

Hepatology international·2026

[From PCOS to PMOS: nomenclature revision and paradigm shift in disease perception].

Zhonghua yi xue za zhi·2026

[Analysis of risk factors for central diabetes insipidus in Langerhans cell histiocytosis].

Zhonghua yi xue za zhi·2026

[Neuroimaging features of white matter lesions related to patent foramen ovale].

Zhonghua yi xue za zhi·2026

[Effect and mechanism of chloroquine on supressing the growth of pancreatic neuroendocrine tumors].

Zhonghua yi xue za zhi·2026

[Development of a prediction model for acute heart failure based on B-type natriuretic peptide and multiple clinical indicators in acute dyspnea patients with varying renal function levels].

Zhonghua yi xue za zhi·2026

[Screening efficacy of different evaluation indicators of peak expiratory flow for chronic obstructive pulmonary disease and the assessment efficacy of the severity of airflow limitation].

Zhonghua yi xue za zhi·2026

Bilateral Primary Breast Cancer: Current Evidence and Future Perspectives.

Breast cancer (Dove Medical Press)·2026

A MAGIBU-based model for pediatric and juvenile CNS tumors: an in-house epigenetic decision-support framework compared with online DNA methylation classifiers.

Free neuropathology·2026

Differentiating Pure and Mixed Mucinous Breast Carcinoma Using Multimodality Imaging: A Retrospective Single-Center Study.

Medeniyet medical journal·2026

Impact of Systematic Biopsy Core Number on Clinically Significant Prostate Cancer Detection and Complications in MRI-Ultrasound Fusion Biopsy: A Retrospective Cohort Study.

Cancer management and research·2026

Oxidative stress-driven epigenetic reprogramming of immune cells in COPD: from epitranscriptomic and metabolic crosstalk to treatable traits.

Frontiers in immunology·2026

Serum BAFF and GDF11: cross-sectional associations with glycolipid metabolism and subclinical carotid artery wall thickening in elderly type 2 diabetes patients.

Frontiers in cardiovascular medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us